Mirati Therapeutics

-$5.23 (-3.20%) Today
+$5.38 (+3.40%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell MRTX and other ETFs, options, and stocks.

About MRTX

Mirati Therapeutics, Inc. operates as a clinical-stage oncology company, which engages in the development of novel therapeutics. The firm's products targets the genetic and immunological promoters of cancer.

CEO
Charles M. Baum
Employees
201
Headquarters
San Diego, California
Founded
1995

MRTX Key Statistics

Market Cap
8.72B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
336.12K
High Today
$167.39
Low Today
$155.53
Open Price
$163.48
Volume
440.94K
52 Week High
$249.42
52 Week Low
$121.79

MRTX Earnings

-$2.67
-$1.78
-$0.89
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 17, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure